Match!
Massimo Volpe
Sapienza University of Rome
948Publications
65H-index
32.1kCitations
Publications 948
Newest
Published on Nov 1, 2018in International Journal of Cardiology3.47
Vivianne Presta4
Estimated H-index: 4
(Sapienza University of Rome),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome),
Massimo Volpe65
Estimated H-index: 65
(Sapienza University of Rome)
Published on Apr 1, 2019in International Journal of Cardiology3.47
Massimo Volpe65
Estimated H-index: 65
(Sapienza University of Rome),
Giovanna Gallo3
Estimated H-index: 3
(Sapienza University of Rome),
Giuliano Tocci24
Estimated H-index: 24
(Sapienza University of Rome)
Abstract The 2018 European and 2017 American guidelines recommend to start antihypertensive treatment with combinations of two or more drugs in most hypertensive patients, as a consequence of the suggested more ambitious blood pressure (BP) targets (systolic BP between 130 and 120 mmHg in most patients, diastolic BP between 80 and 70 mmHg). Monotherapy, however, is still suggested as first choice in some specific classes of patients. In this article, we analyze the subgroups of hypertensive pati...
Published on Sep 1, 2019in Hypertension7.02
Sarassunta Ucci (Sapienza University of Rome), Allegra Battistoni9
Estimated H-index: 9
(Sapienza University of Rome)
+ 5 AuthorsCarmine Savoia24
Estimated H-index: 24
(Sapienza University of Rome)
Published on Aug 28, 2019in Annual Review of Physiology17.90
Valentina Perrone12
Estimated H-index: 12
,
Chiara Veronesi5
Estimated H-index: 5
+ 5 AuthorsMassimo Volpe65
Estimated H-index: 65
(Sapienza University of Rome)
Introduction Polytherapy is often required to treat the comorbidity of hypertension and hyperlipidemia. Fixed-dose co-formulation, rather than free combinations, simplifies medication taking and also improves adherence to medication, which is the key for a successful management of these conditions.
Speranza Rubattu35
Estimated H-index: 35
,
Massimo Volpe65
Estimated H-index: 65
The natriuretic peptides (NPs) family includes a class of hormones and their receptors needed for the physiological control of cardiovascular functions. The discovery of NPs provided a fundamental contribution into our understanding of the physiological regulation of blood pressure, and of heart and kidney functions. NPs have also been implicated in the pathogenesis of several cardiovascular diseases (CVDs), including hypertension, atherosclerosis, heart failure, and stroke. A fine comprehension...
Published on Aug 1, 2019in Journal of Cardiovascular Medicine1.43
Luca Rosario Limite2
Estimated H-index: 2
,
Giacomo Tini2
Estimated H-index: 2
+ 7 AuthorsMaria Beatrice Musumeci9
Estimated H-index: 9
Published on Jul 1, 2019in International Journal of Cardiology3.47
Salvatore Raffa19
Estimated H-index: 19
(Sapienza University of Rome),
Xiao Lan Diana Chin + 12 AuthorsLeonardo Schirone4
Estimated H-index: 4
(Sapienza University of Rome)
Abstract Background Deficiency of NADH dehydrogenase [ubiquinone], the mitochondrial complex I, represents an emerging mechanism of cardiovascular diseases. Ndufc2, a subunit of mitochondrial complex I, is involved in stroke development. We aimed to gain some insights on the role of Ndufc2 into acute coronary syndrome (ACS) through the assessment of its gene expression, along with that of anti-oxidant proteins and of mitochondrial function parameters, in circulating mononuclear cells (PBMCs) of ...
12345678910